← back to search

Melissa Pulitzer

Memorial Sloan Kettering Cancer Center · US
Area of research
Dermatology · Pathology and Forensic Medicine
Research interest
Research interests include Cutaneous lymphoproliferative disorders research, Lymphoma Diagnosis and Treatment, Cutaneous Melanoma Detection and Management, and Melanoma and MAPK Pathways.
h-index
41
citations
8,868
works
246
NIH funding
primary concept
email

Recent publications

European Organisation for Research and Treatment of Cancer, United States Cutaneous Lymphoma Consortium and International Society for Cutaneous Lymphomas consensus recommendations for management and treatment of cutaneous lymphoproliferative disorders
British Journal of Dermatology 2025cited by 6position: middledoi
Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapy
British Journal of Haematology 2024cited by 13position: middledoi
Distinctive genomic features of human T-lymphotropic virus type 1-related adult T-cell leukemia-lymphoma in Western populations
Haematologica 2024cited by 6position: middledoi
Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748
Leukemia 2023cited by 59position: middledoi
Perifollicular linear projections: A dermatoscopic criterion for the diagnosis of lentigo maligna on the face
Journal of the American Academy of Dermatology 2023cited by 11position: middledoi
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms
Leukemia 2022cited by 3,622position: middledoi
In vivo tumor immune microenvironment phenotypes correlate with inflammation and vasculature to predict immunotherapy response
Nature Communications 2022cited by 54position: middledoi
Sézary syndrome and mycosis fungoides: An overview, including the role of immunophenotyping
Cytometry Part B Clinical Cytometry 2020cited by 48position: firstdoi
Updates from the central pathology review in patients with advanced stage mycosis fungoides (MF) and Sezary syndrome (SS) for the Global PROCLIPI study
European Journal of Cancer 2018cited by 0position: middledoi
Primary cutaneous aggressive epidermotropic cytotoxic T-cell lymphomas: reappraisal of a provisional entity in the 2016 WHO classification of cutaneous lymphomas
Modern Pathology 2017cited by 105position: middledoi
<scp>ALK</scp>‐positive primary cutaneous anaplastic large cell lymphoma: a case report and review of the literature
International Journal of Dermatology 2017cited by 21position: middledoi
Mycosis fungoides with large cell transformation: clinicopathological features and prognostic factors
Pathology 2014cited by 85position: firstdoi
Primary cutaneous B-cell lymphomas
Journal of the American Academy of Dermatology 2013cited by 87position: middledoi
Primary cutaneous B-cell lymphomas
Journal of the American Academy of Dermatology 2013cited by 87position: middledoi
Immunohistochemical Analysis of BRAFV600E Expression of Primary and Metastatic Melanoma and Comparison With Mutation Status and Melanocyte Differentiation Antigens of Metastatic Lesions
The American Journal of Surgical Pathology 2012cited by 103position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Patricia L. Myskowski · Kettering University4 papers (2013–2017)Christiane Querfeld · City Of Hope National Medical Center3 papers (2013–2014)Alison J. Moskowitz · Janssen (United States)3 papers (2013–2017)Sarah McCue Horwitz · International School of Management3 papers (2013–2014)Klaus J. Busam · Memorial Sloan Kettering Cancer Center2 papers (2012–2023)Andrea Suárez · University of California, Los Angeles2 papers (2013–2013)Joan Guitart · Northwestern Memorial Hospital2 papers (2017–2018) · 1 papers (2017–2017)Alejandro A. Gru · Columbia University Irving Medical Center1 papers (2018–2018)Anthony Rossi · Memorial Sloan Kettering Cancer Center1 papers (2023–2023)Michael A. Marchetti · Memorial Sloan Kettering Cancer Center1 papers (2023–2023) · 1 papers (2017–2017) · 1 papers (2020–2020)Madeleine Duvic · The University of Texas MD Anderson Cancer Center1 papers (2017–2017) · 1 papers (2017–2017)Maria Estela Martínez‐Escala · University of Chicago1 papers (2017–2017)Natalia Jaimes · University of Miami1 papers (2023–2023)B. Connolly · Gonzaga University1 papers (2014–2014) · 1 papers (2018–2018)Gary S. Wood · University of Wisconsin Carbone Cancer Center1 papers (2017–2017)